Shares of Omega Healthcare Investors Inc (NYSE:OHI) have earned an average rating of “Hold” from the eleven brokerages that are covering the firm, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $40.48.
Several research analysts recently issued reports on the stock. Berenberg Bank assumed coverage on shares of Omega Healthcare Investors in a research note on Thursday, September 12th. They set a “buy” rating and a $47.00 target price on the stock. Zacks Investment Research lowered shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, August 21st. Raymond James increased their target price on shares of Omega Healthcare Investors from $42.00 to $44.00 and gave the stock a “strong-buy” rating in a research note on Thursday, September 12th. Finally, Wells Fargo & Co increased their target price on shares of Omega Healthcare Investors from $36.00 to $40.00 and gave the stock a “market perform” rating in a research note on Friday, August 23rd.
NYSE OHI traded up $0.28 on Friday, hitting $42.03. The company’s stock had a trading volume of 17,110 shares, compared to its average volume of 1,509,234. The company has a quick ratio of 2.78, a current ratio of 2.78 and a debt-to-equity ratio of 1.17. Omega Healthcare Investors has a 1-year low of $31.69 and a 1-year high of $41.99. The company’s 50-day moving average is $39.99 and its 200 day moving average is $37.50. The firm has a market cap of $9.11 billion, a PE ratio of 13.81, a PEG ratio of 5.43 and a beta of 0.37.
In other news, CEO C Taylor Pickett sold 5,500 shares of the stock in a transaction dated Monday, July 8th. The shares were sold at an average price of $38.00, for a total value of $209,000.00. Following the completion of the sale, the chief executive officer now owns 227,933 shares in the company, valued at $8,661,454. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Robert O. Stephenson sold 10,000 shares of the stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $39.00, for a total transaction of $390,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 48,500 shares of company stock valued at $1,926,300. 1.16% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of OHI. Coastal Investment Advisors Inc. boosted its position in Omega Healthcare Investors by 148.4% during the second quarter. Coastal Investment Advisors Inc. now owns 683 shares of the real estate investment trust’s stock worth $26,000 after purchasing an additional 408 shares during the period. Krane Funds Advisors LLC bought a new position in Omega Healthcare Investors during the second quarter worth about $25,000. Redhawk Wealth Advisors Inc. bought a new position in Omega Healthcare Investors during the second quarter worth about $31,000. Phocas Financial Corp. bought a new position in Omega Healthcare Investors during the second quarter worth about $32,000. Finally, Kavar Capital Partners LLC bought a new position in Omega Healthcare Investors during the second quarter worth about $33,000. Institutional investors and hedge funds own 69.29% of the company’s stock.
About Omega Healthcare Investors
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Recommended Story: Marijuana Stocks Investing Considerations
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.